Importance of pharmacokinetic studies in the management of acquired factor X deficiency

European Journal of Haematology
Ming Y LimAlice D Ma

Abstract

Up to 14% of individuals with systemic AL amyloidosis develop acquired factor X deficiency, which occurs due to adsorption of factor X onto amyloid fibrils. Although baseline factor X levels are not predictive of bleeding risk in these patients, serious hemorrhagic complications can occur, particularly during invasive procedures. Optimal management strategies to attenuate bleeding risk in these patients are unknown. We describe our experience in the management of acquired factor X deficiency, secondary to systemic AL amyloidosis, in a case series of three patients who received prothrombin complex concentrates (PCCs) for treatment and prevention of bleeding events. We performed a retrospective review extracting information on baseline demographics, laboratory data, pharmacokinetic (PK) studies, and clinically documented bleeding events. Our case series demonstrates that individuals with acquired factor X deficiency secondary to amyloidosis have variable laboratory and clinical responses to PCCs. This is likely due to distinct amyloid loads and fibril sequences, leading to different binding avidities for factor X. Our data emphasize the importance of performing PK testing prior to any invasive procedures to determine the dose and...Continue Reading

References

Apr 2, 1981·The New England Journal of Medicine·B FurieB C Furie
Sep 28, 1999·Thrombosis Research·M Köhler
Sep 6, 2000·British Journal of Haematology·A D MumfordM Laffan
Apr 12, 2001·British Journal of Haematology·L Boggio, D Green
Mar 17, 2004·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Kazuaki TakabeMichael Bouvet
Feb 27, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Don C RockeyUNKNOWN American Association for the Study of Liver Diseases
Sep 17, 2013·Haemophilia : the Official Journal of the World Federation of Hemophilia·P ChaudharyA Gajra

❮ Previous
Next ❯

Citations

Dec 7, 2019·Hematology·Marzia MenegattiFlora Peyvandi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.